List of Contributions

Danielle Pennant

Contact Details

Contributions

1 to 5 of 6 total
Posted By Danielle Pennant 28-Jun-2024 17:23
Found In Egroup: San Francisco Bay Area Chapter
\ view thread
Wednesday, 10 Jul 2024 (12:00 PM - 01:00 PM) Pacific Time (US & Canada) 1.0 RAC Join us for an enlightening online event where leaders from Lexim AI, explore the unprecedented potential of artificial intelligence within the intricate realm of MedTech regulatory intelligence. Whether ...
Posted By Danielle Pennant 12-Jun-2024 14:56
Found In Egroup: San Francisco Bay Area Chapter
\ view thread
Wednesday, 26 Jun 2024 (05:30 PM - 07:30 PM) Pacific Time (US & Canada) 1.0 RAC Credit Cell and gene therapies have had a tremendous impact on the lives of patients who benefitted from them to date, but their promise is still larger: the fast-developing field of cell therapy continues to ...
Posted By Danielle Pennant 12-Jun-2024 14:37
Found In Egroup: San Francisco Bay Area Chapter
\ view thread
Friday, 14 Jun 2024 (12:00 PM - 01:00 PM) Eastern Time (US & Canada) 1.0 RAC Credit This workshop will be hosted by both the Ontario Chapter and the San Francisco Chapter. Your company wants to use social media to promote your medical device. Where to start? This session will discuss ...
Posted By Danielle Pennant 22-May-2024 13:20
Found In Egroup: San Francisco Bay Area Chapter
\ view thread
Thursday, 23 May 2024 (12:00 PM - 01:00 PM) Pacific Time (US & Canada) 1.0 RAC Credit The EU-MDR amending regulation (EU) 2023/607, allows Manufacturers to place MDD CE marked devices on the European market up to December 2027 and 2028, if a set of conditions ensuring the safety and effectiveness ...
Posted By Danielle Pennant 20-Feb-2024 10:49
Found In Egroup: San Francisco Bay Area Chapter
\ view thread
Friday, 23 Feb 2024 (12:00 PM - 01:00 PM) Pacific Time (US & Canada) 1 RAC Credit The San Francisco Bay Area Chapter will be hosting a webinar - hope you can join us! As we start the new year, regulatory professionals are looking ahead and asking a simple question: What's on FDA's ...